Pinghan Huang
发表
D. Gifford,
Qiaobing Xu,
Ying K. Tam,
2022,
bioRxiv.
Design of SARS-CoV-2 protease inhibitors with improved affinity and reduced sensitivity to mutations
Michael Z. Lin,
C. Blish,
A. Drelich,
2023,
bioRxiv.
C. Blish,
C. Tseng,
S. Einav,
2024,
Science Translational Medicine.